Literature DB >> 15578689

Family history of cancer and the risk of prostate cancer and benign prostatic hyperplasia.

Eva Negri1, Claudio Pelucchi, Renato Talamini, Maurizio Montella, Silvano Gallus, Cristina Bosetti, Silvia Franceschi, Carlo La Vecchia.   

Abstract

We analysed the relation between family history of cancer in first-degree relatives and risk of prostate cancer (PC) and benign prostatic hyperplasia (BPH) using data from a multicentric case-control study conducted in Italy from 1991 to 2002 on 1,294 cases of incident, histologically confirmed PC, 1,369 cases of BPH and 1,451 men admitted to the same network of hospitals for acute, nonneoplastic conditions. Unconditional logistic regression was used to estimate odds ratios (OR) of PC and BPH, adjusted for age and other confounders. Men with a family history of PC had an OR of PC of 4.0 (95% confidence interval [CI] 2.5-6.5), and the risk was higher when the proband was younger, when 2 or more relatives were affected or when the affected relative was a brother. The risk of PC was also increased in men with a family history of cancer of the ovary (OR = 6.2, 95% CI 1.2-32), bladder (OR = 3.5, 95% CI 1.6-7.4) and kidney (OR = 3.1, 95% CI 1.1-8.5). An involvement of breast/ovarian cancer predisposition genes in a small proportion of PCs was suggested by the cluster of these cancers in female relatives of a few PC cases. The risk of BPH was increased in men with a family history of bladder cancer (OR = 2.2, 95% CI 1.0-5.0) but not PC (OR = 1.2, 95% CI 0.7-2.2). Our study adds further information on the association of family history of cancer and risk of PC and is, to our knowledge, the first comprehensive epidemiologic information on family history of cancer and risk of BPH.

Entities:  

Mesh:

Year:  2005        PMID: 15578689     DOI: 10.1002/ijc.20755

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

Review 1.  Benign Prostatic Hyperplasia: Review of Modern Minimally Invasive Surgical Treatments.

Authors:  Tony Nimeh; Brenden Magnan; Y Zaki Almallah
Journal:  Semin Intervent Radiol       Date:  2016-09       Impact factor: 1.513

2.  Meta-analysis of vitamin D receptor gene polymorphisms and benign prostatic hyperplasia risk.

Authors:  Xian-Tao Zeng; Qi-Sheng Yao; Hong Weng; Sheng Li; Jing-Yu Huang; Xing-Huan Wang
Journal:  Mol Biol Rep       Date:  2014-07-03       Impact factor: 2.316

3.  Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study.

Authors:  Jennifer L Beebe-Dimmer; Cecilia Yee; Michele L Cote; Nancie Petrucelli; Nynikka Palmer; Cathryn Bock; Dorothy Lane; Ilir Agalliu; Marcia L Stefanick; Michael S Simon
Journal:  Cancer       Date:  2015-03-09       Impact factor: 6.860

4.  Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era.

Authors:  Yen-Ching Chen; John H Page; Rong Chen; Edward Giovannucci
Journal:  Prostate       Date:  2008-10-01       Impact factor: 4.104

5.  An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis.

Authors:  Michał Kiciński; Jaco Vangronsveld; Tim S Nawrot
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

6.  Association of BID SNPs (rs8190315 and rs2072392) and clinical features of benign prostate hyperplasia in Korean population.

Authors:  Hosik Seok; Su Kang Kim; Koo Han Yoo; Byung-Cheol Lee; Young Ock Kim; Joo-Ho Chung
Journal:  J Exerc Rehabil       Date:  2014-12-31

7.  Association of a Missense ALDH2 Single Nucleotide Polymorphism (Glu504Lys) With Benign Prostate Hyperplasia in a Korean Population.

Authors:  Hosik Seok; Koo Han Yoo; Young Ock Kim; Joo-Ho Chung
Journal:  Int Neurourol J       Date:  2013-12-31       Impact factor: 2.835

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.